NCT05724004View on ClinicalTrials.gov

Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2031

Conditions
Radiotherapy Side EffectNon-small Cell Lung CancerALK Gene Mutation
Interventions
RADIATION

SBRT/SRS/radiation therapy

Consolidation radiation therapy (SBRT/SRS/moderately hypofractionated radiation therapy)

Trial Locations (1)

171 76

RECRUITING

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

Karolinska University Hospital

OTHER